ImmunoGen, Inc is a biotechnology business based in the US. ImmunoGen shares (IMGN) are listed on the NASDAQ and all prices are listed in US Dollars. ImmunoGen employs 79 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in ImmunoGen
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IMGN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ImmunoGen stock price (NASDAQ: IMGN)Use our graph to track the performance of IMGN stocks over time.
ImmunoGen shares at a glance
|Latest market close||$6.18|
|52-week range||$3.38 - $10.88|
|50-day moving average||$6.31|
|200-day moving average||$7.41|
|Wall St. target price||$9.93|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.19|
Buy ImmunoGen shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ImmunoGen stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ImmunoGen price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-11.21%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
|Revenue TTM||$134.7 million|
|Gross profit TTM||$17.7 million|
|Return on assets TTM||-5.2%|
|Return on equity TTM||-109.61%|
|Market capitalisation||$1.1 billion|
TTM: trailing 12 months
Shorting ImmunoGen shares
There are currently 22.1 million ImmunoGen shares held short by investors – that's known as ImmunoGen's "short interest". This figure is 4.1% down from 23.1 million last month.
There are a few different ways that this level of interest in shorting ImmunoGen shares can be evaluated.
ImmunoGen's "short interest ratio" (SIR)
ImmunoGen's "short interest ratio" (SIR) is the quantity of ImmunoGen shares currently shorted divided by the average quantity of ImmunoGen shares traded daily (recently around 2.0 million). ImmunoGen's SIR currently stands at 10.82. In other words for every 100,000 ImmunoGen shares traded daily on the market, roughly 10820 shares are currently held short.
However ImmunoGen's short interest can also be evaluated against the total number of ImmunoGen shares, or, against the total number of tradable ImmunoGen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ImmunoGen's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 ImmunoGen shares in existence, roughly 110 shares are currently held short) or 0.1225% of the tradable shares (for every 100,000 tradable ImmunoGen shares, roughly 123 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against ImmunoGen.
Find out more about how you can short ImmunoGen stock.
ImmunoGen share dividends
We're not expecting ImmunoGen to pay a dividend over the next 12 months.
ImmunoGen share price volatility
Over the last 12 months, ImmunoGen's shares have ranged in value from as little as $3.38 up to $10.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmunoGen's is 1.3036. This would suggest that ImmunoGen's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ImmunoGen, Inc. , a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm. Its preclinical program include IMGC936, an investigational ADC in co-development with MacroGenics, Inc. ImmunoGen, Inc. has collaborations with Roche; Amgen/Oxford BioTherapeutics; sanofi-aventis U. S.
Stocks similar to ImmunoGen
ImmunoGen in the news
Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for
First Week of IMGN September 17th Options Trading
First Week of IMGN September 17th Options Trading
Frequently asked questionsWhat percentage of ImmunoGen is owned by insiders or institutions?
Currently 0.507% of ImmunoGen shares are held by insiders and 92.87% by institutions. How many people work for ImmunoGen?
Latest data suggests 79 work at ImmunoGen. When does the fiscal year end for ImmunoGen?
ImmunoGen's fiscal year ends in December. Where is ImmunoGen based?
ImmunoGen's address is: 830 Winter Street, Waltham, MA, United States, 02451-1477 What is ImmunoGen's ISIN number?
ImmunoGen's international securities identification number is: US45253H1014 What is ImmunoGen's CUSIP number?
ImmunoGen's Committee on Uniform Securities Identification Procedures number is: 45253H101
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert